Abstract
Toxic epidermal necrolysis (TEN) is a life-threatening acute mucocutaneous syndrome. It is characterized by keratinocyte necrosis and apoptosis, which affect more than 30% of the body's surface. TEN is most commonly due to an altered immunological response to specific drugs, infections, and malignancies, or it can be idiopathic. The combination of TEN and COVID-19 can have a fatal outcome if not recognized and promptly treated. Therefore, fast reporting of such cases will draw doctors’ attention to quick and right intervention. In this article, we present a 66-year-old patient with a clinical presentation of toxic epidermal necrolysis along with a coexisting COVID-19 infection. To our knowledge, this is the first case of TEN in a patient diagnosed with SARS CoV‑2 infection in Saudi Arabia.
Reference11 articles.
1. Sekula P, Dunant A, Mockenhaupt M, et al. Comprehensive survival analysis of a cohort of patients with Stevens–Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013; 133(5): pp. 1197–1204.
2. Yang M-S, Lee JY, Kim J, Kim G-W, Kim B-K, Kim J-Y, et al. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: A nationwide population-based study using National Health Insurance Database in Korea [Internet]. PloS one. Public Library of Science; 2016 [cited 27 Jun 2022]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106005/#!po=12.5000
3. Alajaji A, Chandra Shekaran J, Mohammed Aldhabbah O, Alhindi HA, Almazyad NS, Aljutayli ZA, et al. Toxic epidermal necrolysis (TEN)/Stevens-Johnson syndrome (SJS) epidemiology and mortality rate at King Fahad Specialist Hospital (KFSH) in Qassim region of Saudi Arabia: A retrospective study [Internet]. Dermatology Research and Practice. Hindawi; 2020 [cited 27 June 2022]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568810/
4. Labib A, Milroy C. Toxic epidermal necrolysis [Internet]. Ncbi.nlm.nih.gov. 2022 [cited 27 June 2022]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK574530/
5. Saha M. Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with intravenous immunoglobulin: ‘Killing 2 birds with one stone’ [Internet]. En.x-mol.com. 2022 [cited 21 July 2022]. Available from: https://en.x-mol.com/paper/article/1295772431962218496